HCW Biologics (HCWB) Total Current Liabilities (2020 - 2025)
HCW Biologics' (HCWB) quarterly Total Current Liabilities came in at $21.1 million in Q4 2025, down 28.91% YoY from $29.6 million in Q4 2024, and down 21.58% on a QoQ basis from $26.9 million in Q3 2025.
HCW Biologics (HCWB) Total Current Liabilities (2020 - 2025) Analysis & Trends
HCW Biologics (HCWB) has 6 years of Total Current Liabilities data on file, last reported at $21.1 million in Q4 2025.
- Quarterly Total Current Liabilities fell 28.91% year-over-year to $21.1 million in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $21.1 million (down 28.91% YoY) and the FY2025 annual result came in at $21.1 million, down 28.91% from the prior year.
- Total Current Liabilities declined to $21.1 million in Q4 2025, from $26.9 million in the prior quarter.
- In the past five years, Total Current Liabilities ranged from a high of $30.1 million in Q3 2024 to a low of $1.1 million in Q2 2022.
- A 5-year average of $12.5 million and a median of $5.4 million in 2023 frame the typical range for Total Current Liabilities.
- Annual changes were most pronounced in 2022 — Total Current Liabilities tumbled 72.55% — and 2024, when it jumped 455.01%.
- Tracing HCWB's Total Current Liabilities over 5 years: stood at $2.3 million in 2021, then increased by 27.35% to $3.0 million in 2022, then surged by 195.88% to $8.7 million in 2023, then soared by 238.71% to $29.6 million in 2024, then declined by 28.91% to $21.1 million in 2025.
- The last three Total Current Liabilities figures came in at $21.1 million (Q4 2025), $26.9 million (Q3 2025), and $26.8 million (Q2 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Total Current Liabilities (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn | 3.94 Bn |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn | 5.53 Bn |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn | 1.58 Bn |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn | 2.53 Bn |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn | 2.12 Bn |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn | 1.51 Bn |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn | 2.49 Bn |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn | 438.74 Mn |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - | 630.93 Mn |
| 10 | HCW Biologics | 2.86 Mn | 2.11 Mn | -93,887.00 | 18.65 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 21.06 Mn |
| Sep 30, 2025 | 26.86 Mn |
| Jun 30, 2025 | 26.85 Mn |
| Mar 31, 2025 | 27.14 Mn |
| Dec 31, 2024 | 29.63 Mn |
| Sep 30, 2024 | 30.06 Mn |
| Jun 30, 2024 | 23.22 Mn |
| Mar 31, 2024 | 13.41 Mn |
| Dec 31, 2023 | 8.75 Mn |
| Sep 30, 2023 | 5.42 Mn |
| Jun 30, 2023 | 4.54 Mn |
| Mar 31, 2023 | 4.52 Mn |
| Dec 31, 2022 | 2.96 Mn |
| Sep 30, 2022 | 2.29 Mn |
| Jun 30, 2022 | 1.14 Mn |
| Mar 31, 2022 | 1.42 Mn |
| Dec 31, 2021 | 2.32 Mn |
| Sep 30, 2021 | 2.39 Mn |
| Jun 30, 2021 | 4.17 Mn |
| Dec 31, 2020 | 1.00 Mn |